PRGO

Perrigo Company plc operates as a leading provider of over-the-counter health and wellness solutions, primarily serving the consumer self-care market. Headquartered in Dublin, Ireland, with operational headquarters in Grand Rapids, Michigan, the company manufactures and distributes store-brand and generic alternatives to name-brand medicines and nutritional products. Perrigo operates through two primary segments: Consumer Self-Care Americas and Consumer Self-Care International, offering approximately 3,000 SKUs across categories including upper respiratory, digestive health, pain management, skincare, and infant formula. The company employs roughly 9,000 people globally and operates multiple manufacturing and distribution facilities across North America and Europe. As one of the world's largest manufacturers of store-brand consumer health products, Perrigo partners with major retailers including Walmart, CVS, and Walgreens to provide affordable alternatives to branded OTC medications. Recent strategic initiatives include the 2021 acquisition of HRA Pharma for $1.8 billion, significantly expanding its prescription pharmaceuticals portfolio, particularly in women's health and rare diseases. The company generates annual revenues exceeding $4 billion and maintains a distinctive business model focused on self-care products that bypass traditional prescription channels, positioning itself at the intersection of accessible healthcare and consumer retail.